Abstract
Mitochondrial diseases are commonly caused by mutated mitochondrial DNA (mtDNA), which in most cases coexists with wild-type mtDNA, resulting in mtDNA heteroplasmy. We have engineered transcription activator-like effector nucleases (TALENs) to localize to mitochondria and cleave different classes of pathogenic mtDNA mutations. Mitochondria-targeted TALEN (mitoTALEN) expression led to permanent reductions in deletion or point-mutant mtDNA in patient-derived cells, raising the possibility that these mitochondrial nucleases can be therapeutic for some mitochondrial diseases.
Access options
Subscription info for Chinese customers
We have a dedicated website for our Chinese customers. Please go to naturechina.com to subscribe to this journal.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.
Accession codes
References
-
1
Schon, E.A., DiMauro, S. & Hirano, M. Nat. Rev. Genet. 13, 878–890 (2012).
-
2
Vafai, S.B. & Mootha, V.K. Nature 491, 374–383 (2012).
-
3
Wallace, D.C. Environ. Mol. Mutagen. 51, 440–450 (2010).
-
4
Bacman, S.R., Williams, S.L., Garcia, S. & Moraes, C.T. Gene Ther. 17, 713–720 (2010).
-
5
Comte, C. et al. Nucleic Acids Res. 41, 418–433 (2013).
-
6
Taylor, R.W., Chinnery, P.F., Turnbull, D.M. & Lightowlers, R.N. Nat. Genet. 15, 212–215 (1997).
-
7
Minczuk, M., Papworth, M.A., Miller, J.C., Murphy, M.P. & Klug, A. Nucleic Acids Res. 36, 3926–3938 (2008).
-
8
Hockemeyer, D. et al. Nat. Biotechnol. 29, 731–734 (2011).
-
9
Sung, Y.H. et al. Nat. Biotechnol. 31, 23–24 (2013).
-
10
Schon, E.A. et al. Science 244, 346–349 (1989).
-
11
Corral-Debrinski, M. et al. Nat. Genet. 2, 324–329 (1992).
-
12
Soong, N.W., Hinton, D.R., Cortopassi, G. & Arnheim, N. Nat. Genet. 2, 318–323 (1992).
-
13
Diaz, F. et al. Nucleic Acids Res. 30, 4626–4633 (2002).
-
14
Jun, A.S., Trounce, I.A., Brown, M.D., Shoffner, J.M. & Wallace, D.C. Mol. Cell Biol. 16, 771–777 (1996).
-
15
Bacman, S.R., Williams, S.L., Duan, D. & Moraes, C.T. Gene Ther. 19, 1101–1106 (2012).
-
16
Carling, P.J., Cree, L.M. & Chinnery, P.F. Mitochondrion 11, 686–692 (2011).
-
17
Moraes, C.T. Trends Genet. 17, 199–205 (2001).
-
18
Szymczak, A.L. et al. Nat. Biotechnol. 22, 589–594 (2004).
-
19
Liddell, L., Manthey, G., Pannunzio, N. & Bailis, A. J. Vis. Exp. e3150 http://dx.doi.org/10.3791/3150 (2011).
-
20
King, M.P. & Attardi, G. Science 246, 500–503 (1989).
-
21
Sciacco, M., Bonilla, E., Schon, E.A., DiMauro, S. & Moraes, C.T. Hum. Mol. Genet. 3, 13–19 (1994).
-
22
Bacman, S.R. & Moraes, C.T. Methods Cell Biol. 80, 503–524 (2007).
-
23
Jun, A.S., Brown, M.D. & Wallace, D.C. Proc. Natl. Acad. Sci. USA 91, 6206–6210 (1994).
-
24
Bayona-Bafaluy, M.P., Blits, B., Battersby, B.J., Shoubridge, E.A. & Moraes, C.T. Proc. Natl. Acad. Sci. USA 102, 14392–14397 (2005).
-
25
Moraes, C.T., Ricci, E., Bonilla, E., DiMauro, S. & Schon, E.A. Am. J. Hum. Genet. 50, 934–949 (1992).
-
26
Martinez, B. et al. J. Neurochem. 78, 1054–1063 (2001).
Acknowledgements
This work was supported by US National Institutes of Health grants 5R01EY010804, 1R01AG036871 and 1R01NS079965, the Muscular Dystrophy Association and The JDM Fund. We thank M. Hirano (Columbia University) for the G14459A cells, F. Delacote (Cellectis bioresearch) for expert assistance in designing TALENs, G. Zhai for critically reading the manuscript and A. Pickrell for critical scientific suggestions.
Author information
Affiliations
Contributions
S.R.B. and S.L.W. designed and conducted most experiments and assisted in writing the manuscript. M.P. assisted in the quantification of mtDNA deletions and in writing the manuscript. S.P. conducted the complex I activity experiments and assisted in writing the manuscript. C.T.M. designed and supervised the project and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–6 and Supplementary Table 1 (PDF 12499 kb)
Rights and permissions
About this article
Cite this article
Bacman, S., Williams, S., Pinto, M. et al. Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs. Nat Med 19, 1111–1113 (2013). https://doi.org/10.1038/nm.3261
Received:
Accepted:
Published:
Issue Date:
Further reading
-
Safeguarding mitochondrial genomes in higher eukaryotes
Nature Structural & Molecular Biology (2020)
-
Maternally inherited mitochondrial respiratory disorders: from pathogenetic principles to therapeutic implications
Molecular Genetics and Metabolism (2020)
-
Molecular basis of Leigh syndrome: a current look
Orphanet Journal of Rare Diseases (2020)
-
Structural Insights into the Specific Recognition of 5-methylcytosine and 5-hydroxymethylcytosine by TAL Effectors
Journal of Molecular Biology (2020)
-
Exogenous peptides are able to penetrate human cell and mitochondrial membranes, stabilize mitochondrial tRNA structures, and rescue severe mitochondrial defects
The FASEB Journal (2020)